The pharmacy will then be liable for infringement - and therein lies the war of attrition AMRN will need to fight - the problem is no one knows for what indication an MD writes the RX for - thereby allowing infringement to slip in and requiring a lengthy, messy, time consuming and expensive process to eliminate such BUT WAIT ...ALL IS NOT LOST ...ENTER
VASTOR - the new enhanced statin (VAscepa plus a statin) - its clear that it must be for CAD and will be impossible to substitute gV for such without revealing direct infringement -
1.) VASTOR is much easier to market Docs know what a statin is and will be immediately attracted to an ENHANCED STATIN OVER A MODIFIED FISH OIL 2.) Infringement is immediately proven preventing such 3.) AMRN captures vast majority of statin market 4.) Stock price soars
Better idea; Fund an ambulance chaser in each state/major city to chase down prescription/patent cases.
<Call this 1-800 number> <Is your health being compromised for a big wigs yearly bonus?> <Are you owed a settlement?> <Is your insurance company stealing your benefits?> <Would you like to work with someone else's prepaid big time lawyer?> <Call this number right now!!!>